CN1219532C - 一种治疗妇科疾病的中药及其制备方法 - Google Patents
一种治疗妇科疾病的中药及其制备方法 Download PDFInfo
- Publication number
- CN1219532C CN1219532C CNB021398054A CN02139805A CN1219532C CN 1219532 C CN1219532 C CN 1219532C CN B021398054 A CNB021398054 A CN B021398054A CN 02139805 A CN02139805 A CN 02139805A CN 1219532 C CN1219532 C CN 1219532C
- Authority
- CN
- China
- Prior art keywords
- radix
- radix angelicae
- medicine
- angelicae sinensis
- atractylodis macrocephalae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims description 4
- 201000010099 disease Diseases 0.000 title abstract description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract description 5
- 241000411851 herbal medicine Species 0.000 title 1
- 239000003814 drug Substances 0.000 claims abstract description 22
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 22
- 239000000843 powder Substances 0.000 claims description 18
- 108010052008 colla corii asini Proteins 0.000 claims description 14
- 229940056582 human hair preparation Drugs 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000002904 solvent Substances 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 8
- 238000005325 percolation Methods 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 238000009495 sugar coating Methods 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 16
- 210000004369 blood Anatomy 0.000 abstract description 15
- 210000000952 spleen Anatomy 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 9
- 230000007812 deficiency Effects 0.000 abstract description 6
- 206010027514 Metrorrhagia Diseases 0.000 abstract description 5
- 238000002360 preparation method Methods 0.000 abstract description 5
- 208000002193 Pain Diseases 0.000 abstract description 4
- 230000001225 therapeutic effect Effects 0.000 abstract description 4
- 208000002173 dizziness Diseases 0.000 abstract description 3
- 238000005728 strengthening Methods 0.000 abstract description 3
- 206010046901 vaginal discharge Diseases 0.000 abstract 2
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract 1
- 241000123589 Dipsacus Species 0.000 abstract 1
- 108010010803 Gelatin Proteins 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 240000004064 Poterium sanguisorba Species 0.000 abstract 1
- 235000008291 Poterium sanguisorba Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 235000008282 Sanguisorba officinalis Nutrition 0.000 abstract 1
- 241000238371 Sepiidae Species 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 210000003756 cervix mucus Anatomy 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 239000008273 gelatin Substances 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 235000011852 gelatine desserts Nutrition 0.000 abstract 1
- 201000005630 leukorrhea Diseases 0.000 abstract 1
- 210000004914 menses Anatomy 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 12
- 239000000047 product Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 7
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- 241000700159 Rattus Species 0.000 description 5
- 210000003743 erythrocyte Anatomy 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 210000004291 uterus Anatomy 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 206010013908 Dysfunctional uterine bleeding Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000005242 forging Methods 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 238000010255 intramuscular injection Methods 0.000 description 2
- 239000007927 intramuscular injection Substances 0.000 description 2
- 208000013433 lightheadedness Diseases 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000013558 reference substance Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- RODXRVNMMDRFIK-UHFFFAOYSA-N scopoletin Chemical compound C1=CC(=O)OC2=C1C=C(OC)C(O)=C2 RODXRVNMMDRFIK-UHFFFAOYSA-N 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- JLTCWSBVQSZVLT-CDIPANDDSA-N (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosan Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](N)CSSC1.C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 JLTCWSBVQSZVLT-CDIPANDDSA-N 0.000 description 1
- FZRCKLPSHGTOAU-UHFFFAOYSA-N 6-amino-1,4-dimethylcyclohexa-2,4-diene-1-carbaldehyde Chemical compound CC1=CC(N)C(C)(C=O)C=C1 FZRCKLPSHGTOAU-UHFFFAOYSA-N 0.000 description 1
- 206010061623 Adverse drug reaction Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 1
- 240000001592 Amaranthus caudatus Species 0.000 description 1
- GJSURZIOUXUGAL-UHFFFAOYSA-N Clonidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- XEHFSYYAGCUKEN-UHFFFAOYSA-N Dihydroscopoletin Natural products C1CC(=O)OC2=C1C=C(OC)C(O)=C2 XEHFSYYAGCUKEN-UHFFFAOYSA-N 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- IBPFZCOJYVDKGN-UHFFFAOYSA-N OC.OC=O.ClC(Cl)Cl.CCOC(C)=O Chemical compound OC.OC=O.ClC(Cl)Cl.CCOC(C)=O IBPFZCOJYVDKGN-UHFFFAOYSA-N 0.000 description 1
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 1
- 102000005320 Posterior Pituitary Hormones Human genes 0.000 description 1
- 108010070873 Posterior Pituitary Hormones Proteins 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041954 Starvation Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 239000004178 amaranth Substances 0.000 description 1
- 235000012735 amaranth Nutrition 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 1
- 229910001626 barium chloride Inorganic materials 0.000 description 1
- 229960002896 clonidine Drugs 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N ethyl acetate Substances CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000003643 myeloid progenitor cell Anatomy 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- FWYIBGHGBOVPNL-UHFFFAOYSA-N scopoletin Natural products COC=1C=C2C=CC(OC2=C(C1)O)=O FWYIBGHGBOVPNL-UHFFFAOYSA-N 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 230000016160 smooth muscle contraction Effects 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 239000009306 yunnan baiyao Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021398054A CN1219532C (zh) | 2002-12-06 | 2002-12-06 | 一种治疗妇科疾病的中药及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021398054A CN1219532C (zh) | 2002-12-06 | 2002-12-06 | 一种治疗妇科疾病的中药及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1480173A CN1480173A (zh) | 2004-03-10 |
CN1219532C true CN1219532C (zh) | 2005-09-21 |
Family
ID=34147507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB021398054A Expired - Fee Related CN1219532C (zh) | 2002-12-06 | 2002-12-06 | 一种治疗妇科疾病的中药及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1219532C (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101119740B (zh) * | 2004-12-14 | 2012-02-29 | 成都地奥制药集团有限公司 | 中药地榆及其提取物在制备升高红细胞和血红蛋白药物中的应用 |
CN101502634B (zh) * | 2009-03-06 | 2011-11-02 | 陈殿红 | 一种治疗宫血的中药组合物及其制备方法 |
CN101856431B (zh) * | 2010-06-02 | 2011-08-31 | 南京中医药大学 | 用于治疗肝肾阴虚型无排卵型功血的药物及其制备方法和应用 |
CN102100843B (zh) * | 2011-03-11 | 2012-06-20 | 杨萍萍 | 一种治疗室女崩漏的中药组合物及其使用方法 |
CN105434775A (zh) * | 2015-12-07 | 2016-03-30 | 黄卫忠 | 一种治疗带下病的中成药及其制备方法 |
CN106214910A (zh) * | 2016-08-22 | 2016-12-14 | 湖南康尔佳制药股份有限公司 | 一种治疗功能失调性子宫出血的药物及其制备方法 |
CN106418528A (zh) * | 2016-12-27 | 2017-02-22 | 山东鲁健生物医药科技有限公司 | 一种供功能性子宫出血患者食用的保健食品及其制备方法 |
-
2002
- 2002-12-06 CN CNB021398054A patent/CN1219532C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1480173A (zh) | 2004-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101837065B (zh) | 抗肝炎、抗肿瘤及提高机体免疫功能的药物及其制备方法 | |
WO2007009291A1 (fr) | Composition pharmaceutique de médicament traditionnel chinois pour traiter la polyarthrite rhumatoïde et sa préparation | |
CN102091168A (zh) | 一种中药制剂血府逐瘀胶囊的质量控制方法 | |
CN1219532C (zh) | 一种治疗妇科疾病的中药及其制备方法 | |
CN100493579C (zh) | 一种中药组合物及其制备方法和质量控制方法 | |
CN1887324B (zh) | 一种治疗肝肾不足的中药组合物及其制备方法和分析方法 | |
CN100341547C (zh) | 一种具有调节血脂作用的药物组合物及其制备方法和用途 | |
CN102657736B (zh) | 一种治疗类风湿性关节炎的药物组合物及其制备方法 | |
CN1876051A (zh) | 治疗妇科疾病的中药制剂及制备方法和质量控制方法 | |
CN102151318B (zh) | 一种治疗妇科疾病的中药组合物及制法和检测方法 | |
CN101129974A (zh) | 一种治疗肝病的中药组合物及制备方法 | |
CN105535533A (zh) | 一种治疗胃炎的中药组合物 | |
CN1246031C (zh) | 治疗慢性盆腔炎的中成药 | |
CN1272027C (zh) | 治疗泌尿系统结石、感染及胆囊结石、胆囊炎的金钱草制剂及其生产方法 | |
CN111643594B (zh) | 一种用于治疗阿片类药物相关性便秘的中药组合物、其制备方法和应用 | |
CN1712060A (zh) | 一种治疗妇女经期疾病的中药合剂的制备方法 | |
CN1887328A (zh) | 一种中药组合物及其制备方法和质量控制方法 | |
CN101011543B (zh) | 一种新的抗肿瘤药物组合物 | |
CN100434092C (zh) | 含有草木犀成分的组方及其制剂 | |
CN106109625B (zh) | 一种用于心衰治疗的中药制剂的制备方法 | |
CN1241586C (zh) | 一种中药组合物及制备方法、质量控制方法和用途 | |
CN1733287A (zh) | 一种主治子宫肌瘤的中成药和制备、质量控制方法 | |
CN1105878A (zh) | 治疗男性性功能障碍症的药物—中国猛男胶囊 | |
CN111388584A (zh) | 一种治疗阳痿的组合物及其制备方法 | |
CN102309620A (zh) | 一种治疗便秘的中药制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: CHANGSHA KANGERJIA PHARMACY GROUP CO.,LTD. Free format text: FORMER OWNER: CHANGSHA TAIBAO PHARMACEUTICAL CO., LTD. Effective date: 20100121 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20100121 Address after: No. 198, west slope, Tongzi, Hunan, Changsha: 410205 Patentee after: Changsha kaang'er Pharmaceutical Group Co., Ltd. Address before: No. 17 South Shaoshan Road, Hunan, Changsha Patentee before: Taibao Pharmaceutical Co., Ltd., Changsha |
|
ASS | Succession or assignment of patent right |
Owner name: HU'NAN KANGERJIA PHARMACEUTICAL MANAGEMENT GROUP C Free format text: FORMER OWNER: CHANGSHA KANGERJIA PHARMACEUTICAL GROUP CO., LTD. Effective date: 20101119 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20101119 Address after: 410205 No. 198 west slope road, Changsha, Hunan, Tongzi Patentee after: Hunan Kang Medicine Management Group Co., Ltd. Address before: 410205 No. 198 west slope road, Changsha, Hunan, Tongzi Patentee before: Changsha kaang'er Pharmaceutical Group Co., Ltd. |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Hunan Kang Medicine Management Group Co., Ltd. Document name: Notification to Pay the Fees |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Hunan Kang Medicine Management Group Co., Ltd. Document name: Notification of Termination of Patent Right |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050921 Termination date: 20181206 |
|
CF01 | Termination of patent right due to non-payment of annual fee |